Aging stem cells in mice may hold answers to diseases of the aged, Stanford study finds
...the Stanford Comprehensive Cancer Center. The work will be published in the June 6 issue of Nature. In past studies, this group of researchers had shown that blood-forming stem cells in the bone marrow of mice became less able to divide and replenish the supply of blood cells as they aged. The question ...Researchers develop criteria to detect bone mass deficiencies in children with chronic diseases
...oporosis, Dr. Kalkwarf said. The research findings will allow physicians to use standardized data on bone ...ites. This comprehensive evaluation of bone status will determine if certain conditions or treatments affect some skeletal sites differently from others. Th...Rochester spreads knowledge of cancer-related fatigue
...with hope that a better understanding of the topic will prompt new research and treatment. Virtually all cancer patients complain of some degree of persistent fatigue. Coping with this challenging side effect is critical to surviving cancer, especially since many people desire to work, raise children, r...High-Need Physician Workforce Incentives Act endorsed by American College of Physicians
...each year of service at a high-need facility, HRSA will pay up to $35,000 of the principal and interest of... two parts of Rep. Burgesss and Rep. Cuellars bill will create targeted incentives, as ACP previously has proposed, to encourage students to pursue careers ...Heading to Siberia: UH signs agreement with Russian Academy of Sciences
...etter together than ever before. This partnership will facilitate this sharing of talent both on the fac...laborations over a larger spectrum at UH. The MOU will facilitate more direct alliances in the future. Previously, the two institutions partnered in th...Conference to investigate basis of parental behavior
... 7, 2007 Nearly 150 basic and clinical scientists will assemble in Boston this week to better understand ...niversity faculty member Robert S. Bridges, Ph.D., will bring together some of the leading minds on maladaptive parental response to share state-of-the-art ...Research probes seniors' plans for end-of-life care
...g: the choice to appoint a "health care proxy" who will make treatment decisions should a person become in...ent called an advance directive. Medical personnel will also sometimes discuss the issue with patients; however, they tend to employ abstract arguments or a...New study reports hotel guests at risk from carbon monoxide poisoning
...on of CO poisoning to guests, and concluded, AH&LA will continue to monitor industry-related carbon monoxide issues. Until CO alarms are installed in hotels, motels, and resorts, guests should consider carrying a CO alarm when they travel. ...UK scientists set their sights on cure for AMD
...o replace the faulty retinal cells that cause AMD, will be developed by the London Project to Cure AMD, a ...nation from a US private donor, the London Project will now be able to assemble the necessary spectrum of scientists and clinicians, led by the UCL Institut...GSK announces launch of largest ever Phase III trial in lung cancer treatment
...r conducted in lung cancer treatment. MAGE-A3 ASCI will be evaluated as adjuvant therapy in about 2,270 MA...Adjuvant Non-Small Cell Lung Cancer Immunotherapy) will enroll patients with stage IB, II or IIIA resectable NSCLC. The ASCI administration will be initiate...Advances in understanding bipolar disorder topics of press briefings June 7, 8
...r productivity each year. The Seventh Conference will be held June 7-9 at the David L. Lawrence Conventi...enter (UPMC). To accommodate media, a press room will be located in Rooms 310-311 of the Convention Center and will be open 8 a.m. to 5 p.m., Thursday, Ju...Folic acid supplements do not appear to reduce risk of colorectal tumors
...h as larger size, that increase the risk that they will develop into colorectal cancer. In the first follow-up interval, advanced adenomas occurred in 8.6 percent of the participants in the placebo group and 11.4 percent of the participants in the folic acid group. The respective numbers in the second fo...Cedars-Sinai researchers present new endocrine findings at 2 international conferences
...s on human growth hormone and the pituitary gland, will be presenting The Year in Pituitary, an overview o...ent of the International Society of Endocrinology, will also highlight challenges scientists continue to face continue to face as they advance the diagnosis...CIRM awards $3.79 million to Burnham Institute
...on) earlier this year. The funding announced today will make it possible to develop a shared laboratory pr...Burnhams increased demand. This shared laboratory will also support Burnhams partner institutes collaborating as the San Diego Consortium for Regenerative ...USC and Childrens Hospital Los Angeles both receive grants for stem cell facilities
... for Regenerative Medicine (CIRM). These grants will fund dedicated laboratory space and equipment for ...ing an outstanding team of scientists. The funding will help develop more vitally important facilities that are needed for stem cell investigation and the e...DFG approves 11 new Collaborative Research Centers
...ungsgemeinschaft (DFG, German Research Foundation) will establish eleven new Collaborative Research Centres (SFBs) on 1 July 2007. They will receive a total of 75.5 million euros in funding over the next four years. Research conducted in the...Extra pay does not improve hospital performance
... for possible increased payments. These findings will add to the national debate over the use of pay for...the possibility of receiving higher reimbursements will motivate hospitals to improve the quality of their care. A study recently conducted by Premier, In...USC researchers show that molecular markers predict tumor recurrence
... findings may help oncologists target patients who will benefit the most from adjuvant chemotherapy. The treatment remains controversial for stage II patients because the majority do not have tumor relapse, he notes. That means that 70 to 80 percent of stage II patients would be treated with chemotherap...Benefits of trastuzumab are lasting, reducing both HER2 + breast cancer deaths and recurrence
... Society, about 178,480 women in the United States will be diagnosed with invasive breast cancer in 2007. About 40,460 women will die from the disease this year. Right now, more than 2 million women living in the United States hav...